Vineet Laboratories Limited (NSE:VINEETLAB)
India flag India · Delayed Price · Currency is INR
32.00
-0.27 (-0.84%)
May 29, 2025, 12:15 PM IST

Vineet Laboratories Company Description

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and fine chemicals in India.

The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates.

It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde.

The company was founded in 2007 and is based in Hyderabad, India.

Vineet Laboratories Limited
Country India
Founded 2007
Industry Chemicals
Sector Materials
Employees 79
CEO Gaddam Ramana

Contact Details

Address:
5-5-160, Malleswari Nilayam
Hyderabad, 500074
India
Phone 91 40 2412 8833
Website vineetlabs.co.in

Stock Details

Ticker Symbol VINEETLAB
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE505Y01010
SIC Code 2833

Key Executives

Name Position
Gaddam Venkata Ramana Founder, MD and Director
Satyanarayana Raju Bhupathiraju Chief Financial Officer and Whole-time Director
Kandula Murali Mohan General Manager of Operations
Rameshkumar Bandari Company Secretary and Compliance Officer
M. Venkata Ramana Ravi Senior Manager of Marketing
Pavani Srinivasa Rao Manager of Human Resources
B V Ramakrishna Manager Accounts and Finance Permanent